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Abstract Reactive oxygen species (ROS) primarily arise from
products of normal metabolic activities and are thought to be the
etiology of many diseases. A novel dicyclodextrinyl ditelluride
(2-TeCD) compound was designed to be a functional mimic of the
glutathione peroxidase that normally removes ROS. 2-TeCD
exhibited highly catalytic efficiency and good water solubility.
Antioxidant activity was studied by using ferrous sulfate/
ascorbate-induced mitochondria damage model system. 2-TeCD
protected the mitochondria against oxidative damage in a dose-
dependent manner and exhibited also great antioxidant ability in
comparison with 2-phenyl-1,2-benziososelenazol-3(2H)-one. The
mimic may result in better clinical therapies for the treatment of
ROS-mediated diseases. ß 2001 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Reactive oxygen species (ROS), such as superoxide anion,
H2O2, organic peroxide, and hydroxyl radical are products of
normal metabolic activities and are produced in response to
various stimuli. Under normal conditions, there is a balance
between the production of ROS and their destruction. In cer-
tain diseases, the production of ROS is enhanced and then
ROS damage biomacromolecules [1], resulting in ROS-medi-
ated cell injury. Examples of such oxidative stress-related dis-
eases include reperfusion injury, in£ammatory process, age-
related diseases, neuronal apoptosis, cancer, and cataract
[2^4]. To prevent undesired ROS-induced damage, organisms
are equipped with several lines of antioxidant defense. These
act either as non-enzymatic action (vitamine E, ascorbate,
glutathione (GSH), and uric acid) or as enzymatic action
(superoxide dismutase, catalase, and glutathione peroxidase
(GPX)).
Because of the limitations associated with enzyme therapies
(solution instability, short half-lives, costs of production, and
proteolytic digestion), considerable e¡orts have been made to
¢nd compounds that could mimic the properties of the GPX
[5,6]. 2-Phenyl-1,2-benziososelenazol-3(2H)-one (Ebselen) was
the ¢rst compound found to have this capacity [7] and is
currently undergoing phase III clinical trial in Japan as an
antioxidant [5], but it has some drawbacks, such as low
GPX activity and water insolubility.
General conclusion from work on models is that an e⁄cient
enzyme mimic involves the substrate binding and the subse-
quent intracomplex catalysis [8,9]. Cyclodextrins (CDs) have
been extensively exploited in the past as a variety of enzyme
models and molecular receptors because of their abilities to
bind various hydrophobic compounds into their hydrophobic
cavities via host^guest chemistry [10,11]. Based on CD as an
enzyme model, we here reported a novel GPX mimic (dicy-
clodextrinyl ditelluride (2-TeCD)) that catalyzes the decompo-
sition of hydroperoxides with remarkably high GPX activity
exceeding other small mimics of GPX. The biological e¡ect of
2-TeCD was evaluated by the protection of mitochondria
against oxidative damage and it was found to be a better
antioxidant than Ebselen. 2-TeCD exhibited high GPX activ-
ity and good water solubility, therefore has obvious advan-
tages for pharmacological application.
2. Materials and methods
2.1. Apparatus and materials
The characterization of structure of the mimic was performed with
a Varian Unity-400 NMR spectrometer, a Bruker IFS-FT66V Infra-
red spectrometer and a Perkin-Elmer 240 DS Elemental Analyzer. The
content and valence of tellurium in the mimic were determined using
an ESCALAB MKII X-ray photoelectron spectrometer. The spectro-
metric measurements were carried out using a Shimadzu 3100 UV-
Vis-near-IR Spectrophotometer interfaced with a personal computer.
L-CD was purchased from Tianjin Chemical Plant, recrystallized
twice from water. 2-SeCD was prepared as described previously
[12]. p-Toluene sulfochloride and tert-butylhydroperoxide (t-BuOOH)
were also obtained from Tianjin Chemical Plant. Tellurium, sodium
borohydride, GSH, L-nicotinamide adenine dinucleotide phosphate
(NADPH), cumene hydroperoxide (CuOOH), Ebselen, and GSH re-
ductase (type III) were purchased from Sigma. Thiobarbituric acid
(TBA) and ferrous sulfate were obtained from Shanghai Second Re-
agent Plant. Ascorbic acid was purchased from Fluka. Sephadex G-25
was purchased from Amersham Pharmacia Biotech, Uppsala, Sweden.
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All other chemicals were of the analytic purity commercially available
and were used without further puri¢cation.
2.2. Synthesis of 2, 2P-tellurium bridged L-CD (2-TeCD)
The 2-OTs-2-deoxy-L-CD (2-OTs-L-CD) was prepared as described
previously [12]. Finely ground elemental tellurium (1.27 g) and sodium
borohydride (0.9 g) were heated in ethanol (20 ml) at re£ux under
nitrogen for 1 h. After cooling to ambient temperature, acetic acid
free of oxygen (1.2 ml) was added to the solution. 2-OTs-L-CD (2 g)
dissolved in 50 mM potassium phosphate bu¡er, pH 7.0 (20 ml), was
bubbled using pure nitrogen for 30 min and added to the above so-
lution. Under the protection of nitrogen, the mixture was kept for 48 h
at 60‡C, and then was oxidized in air, ¢nally puri¢ed by centrifuga-
tion and Sephadex G-25 column chromatography. The product solu-
tion was freeze-dried and the lyophilized powder was yellow product
with 62% yield. The structure of 2-TeCD was analyzed by means of
elemental analysis, IR, 1H NMR, 13C NMR. The data were shown as
follows: Anal. (C84H138O68Te2W6H2O) C, H. Calcd: C, 38.32; H, 5.58.
Found: C, 37.87; H, 5.65. IR (KBr): 3367 (^OH), 2928 (CH, CH2),
1630, 1154, 1083, 1027 (^O^), 947, 753, 705, 583. 1H NMR (400 MHz,
DO) N : 4.99 (1-H), 4.0^3.65 (3-, 5-, 6-H), 3.65^3.28 (2-, 4-H). 13C
NMR (400 MHz DO) N : 100.8 (1-C), 98.5 (1P-C), 80.1 (4-c), 75.9
(2P-C), 72.3 (2-c), 70.9 (3-, 5-, 5P-C), 68.3 (3P-C), 59.5 (6-, 6P-C). The
content and valence of tellurium in the mimic were determined by
X-ray photoelectron spectroscopy. The energy of the exciting X-ray
was 1253.6 eV (Mg, KK). C1s = 285.0 eV was served as standard. The
scans were performed 10 times.
2.3. Assay of enzymatic property of 2-TeCD
GPX activities were examined by following the oxidation of
NADPH in the presence of GSH reductase, which catalyzes the re-
duction of oxidized GSH formed in the catalytic cycle. Both samples
and control cuvettes contained 50 mM potassium phosphate bu¡er,
pH 7.0, 1 mM EDTA, 1 mM sodium azide, 1 mM GSH, 1 U of GSH
reductase in a total volume of 0.5 ml. An aliquot of 2-TeCD was
added to the sample cuvette only. The reaction mixture was started
by the addition of 0.5 mM hydroperoxide in both cuvettes. The re-
action was followed by the decrease of NADPH absorption at 340
nm. The activity was corrected for control experiment. One unit of
enzyme activity is de¢ned as amount of mimic that utilizes 1 Wmol of
NADPH per minute.
2.4. Preparation of mitochondria
Bovine heart mitochondria were isolated from fresh bovine heart
according to ref. [13] and suspended in 0.25 M sucrose, 10 mM EDTA
and 25 mM HEPES^NaOH bu¡er, pH 7.4, and maintained at 0‡C.
The concentration of the mitochondria protein was determined by
Coomassie brilliant blue [14] using bovine serum albumin as the stan-
dard.
2.5. Ferrous sulfate/ascorbate-induced mitochondria damage
The incubation mixture consisted of 0.125 M KCl, 1 mM MgCl2,
5 mM glutamate, mitochondria (0.5 mg protein/ml), 1 WM GSH, and
appropriate enzyme mimic in 10 mM potassium phosphate bu¡er, pH
7.4, 37‡C. TBA reactive substances (TBARS) and swelling of mito-
chondria were determined at some intervals after addition of 0.5 mM
ascorbate and 12.5 WM ferrous sulfate. Damage experiments have
been done without enzyme mimic; control experiments have been
performed without enzyme mimic, ascorbate and ferrous sulfate.
2.6. Biological analysis of 2-TeCD against mitochondria damage
TBARS content in ferrous sulfate/ascorbate-treated mitochondria
was analyzed by TBA assay [15].
Swelling of mitochondria was assayed as described by Hunter at al.
[16]. The swelling of mitochondria was measured as the decrease in
turbidity of the reaction mixture at 520 nm. The decrease of the ab-
sorbance indicates an increase in the mitochondria swelling and a
decrease in the mitochondria integrity.
3. Results
3.1. Synthesis and characterization of 2-TeCD
The route of the synthesis of 2-TeCD is shown in Scheme 1.
2-TeCD was characterized by elemental analysis, IR, 1H
NMR, 13C NMR. The content and valence of tellurium in
2-TeCD were measured by X-ray photoelectron Spectroscopy.
The Te3d5=2 electronic binding energy of 2-TeCD is 574.2 eV,
which approaches the binding energy of diphenyl ditelluride
of 573.9 eV, indicating that the tellurium in 2-TeCD was
presented as the form of 31 valence (ditellurium bridge,
^Te^Te^). The experiment also gave the C/Te, which is
42.3:1 (calculated 42:1), indicating that the mimic contains
2 mol of tellurium per mole mimic.
3.2. Enzymatic property of 2-TeCD
The GPX activities of 2-TeCD and other species are listed
in Table 1. As shown in Table 1, the GPX activity of 2-TeCD
for the reduction of H2O2 by GSH was determined to be 46.7
U/Wmol of 2-TeCD, indicating that 2-TeCD displays more
e⁄cient catalysis than Ebselen [17], diphenyl diselenide (PhSe-
SePh) [17], and 2-SeCD [12]. The 2-TeCD also catalyzes the
reduction of a variety of structurally distinct hydroperoxides,
from the hydrophilic H2O2 to the bulky aromatic CuOOH.
The GPX activities of the 2-TeCD-catalyzed reduction of
t-BuOOH and CuOOH by GSH were determined to be 32.3
and 87.3 U/mol of 2-TeCD, respectively. These results show
that 2-TeCD has di¡erent substrate speci¢city for hydroper-
oxides, and the preferred substrate is CuOOH. The GPX ac-
tivities of the Ebselen-catalyzed reduction of t-BuOOH and
CuOOH were determined to be 0.35 and 1.28 U/Wmol, respec-
tively. As discussed above, the catalytic e⁄ciency of 2-TeCD
for the reduction of organic hydroperoxides was also higher
than that of Ebselen. To gauge further the catalytic e⁄ciency
of 2-TeCD, we compared 2-TeCD with model compound Eb-Scheme 1.
Table 1
Comparison between GPX activities of the 2-TeCD-catalyzed reduc-
tion of hydroperoxides by GSH and other species






2-TeCDa H2O2 46.7 (1.2)
t-BuOOH 32.3 (0.8)
CuOOH 87.3 (0.7)
aReactions were carried out in 50 mM potassium phosphate bu¡er,
pH 7.0, at 37‡C, 1 mM GSH, 0.5 mM hydroperoxide. One unit of
enzyme activity is de¢ned as amount of mimic that utilizes of
1 Wmol of NADPH per minute. All values are means of at least ¢ve
times, and standard deviations are shown in parentheses.
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selen, a well-studied GPX mimic. At 37.0‡C and pH 7.0, the
initial rate of the reduction of H2O2 (0.5 mM) by GSH (1 mM)
in the presence of 1.2 WM of 2-TeCD is 3.2U1035 M/min, but
under the same conditions, when 1.2 WM of Ebselen was used
as the catalyst, the initial rate is only 6.9U1037 M/min. These
data indicate that 2-TeCD is at least 46-fold more e⁄cient
than Ebselen.
3.3. 2-TeCD protection of mitochondria against
oxidative damage
Fig. 1A shows that the mitochondria swell greatly by fer-
rous sulfate/ascorbate-induced mitochondria damage and the
swelling of mitochondria was decreased by the addition of
2-TeCD. The absorbance at 520 nm for the control group
was basically constant, whereas the absorbance for the dam-
age group was decreased considerably with time, indicating
the mitochondria swelling was considerably increased. But,
the swelling for the protection group, which contained a
certain concentration of 2-TeCD, was apparently inhibited,
and the swelling of mitochondria was decreased with an in-
crease of 2-TeCD concentration. The ability of GPX mimics,
2-TeCD, 2-SeCD and Ebselen, to inhibit the swelling of
mitochondria was di¡erent, as evidenced by Fig. 1B, whereas
the 2-TeCD was the best protective among them. This is
in agreement with H2O2 removal activity of these GPX
mimics.
Fig. 2A shows the extent of protection a¡orded by 2-TeCD.
The TBARS amount accumulated during damage of mi-
tochondria was considerably reduced in the presence of
2-TeCD, and the decrease of TBARS amount was increased
with the increase of the concentration of 2-TeCD. When the
2-TeCD concentration was 16 WM, in 50 min the TBARS
content was only 35.8% of the damage group, indicating
that 64.2% of TBARS production was inhibited. In order to
gauge the ability of the three GPX mimics, 2-TeCD, 2-SeCD
and Ebselen, to inhibit TBARS accumulation, their antioxi-
dant activities were undertaken under the identical condition.
As evidenced by Fig. 2B, the ability of 2-TeCD to decrease
the TBARS accumulation was greater than that of 2-SeCD
and Ebselen.
Fig. 1. A: E¡ect of concentration of 2-TeCD on the swelling of mitochondria. (7) Control; (E) damage+16 WM of 2-TeCD; (a) damage+8
WM of 2-TeCD; (O) damage+2 WM of 2-TeCD; (P) damage. B: E¡ect of the di¡erent GPX mimics on the swelling of mitochondria. (7) Con-
trol; (E) damage+8 WM of 2-TeCD; (a) damage+8 WM of 2-SeCD; (O) damage+8 WM of Ebselen; (P) damage. The damage condition is ex-
plained in Section 2.
Fig. 2. A: Dependence of extent of TBARS accumulation on concentration of 2-TeCD. (E) Damage; (a) damage+2 WM of 2-TeCD; (O) dam-
age+8 WM of 2-TeCD; (P) damage+16 WM of 2-TeCD. B: E¡ect of di¡erent GPX mimics on the TBARS accumulated during damage of
mitochondria. (E) Damage; (a) damage+8 WM of Ebselen; (O) damage+8 WM of 2-SeCD; (P) damage+8 WM of 2-TeCD. The damage condi-
tion is explained in Section 2. The absorbance values represent TBARS equivalents and are means of three determinations.
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4. Discussion
Exposing mitochondria in vitro to redox active xenobiotics
can mimic the oxidative damage of mitochondria in vivo. The
reaction for ferrous sulfate/ascorbate-induced mitochondria
damage can be proposed:
Ascorbic acidO2 ! dehydroascorbic acidH2O2 1
Fe2 H2O2 ! Fe3 OH3  OH 2
Ascorbic acid 2Fe3 ! dehydroascorbic acid 2Fe2  2H
3
where H2O2 was produced by oxidation of ascorbic acid to
dehydroascorbic acid, and then hydroxyl radical was pro-
duced via Fenton reaction. The biological molecules in mito-
chondria were easily attacked by hydroxyl radical, then
changes of mitochondria in composition, morphology, struc-
ture, integrity, and function took place. GPX mimics can
scavenge hydroperoxides and block the production of hydrox-
yl radical, and therefore protect mitochondria against oxida-
tive damage.
In ferrous sulfate/ascorbate-induced mitochondria damage
model system, swelling extent and TBARS content were
choose as standard, which was used to determine the injury
and protection extent of mitochondria. 2-TeCD reduced the
swelling of mitochondria during its damage and decreased the
maximal level of TBARS accumulation and also the slope of
rapid phase of TBARS accumulation. The swelling of mito-
chondria and TBARS accumulation decreased by 2-TeCD is a
dose-dependent manner. The reason that 2-TeCD inhibited
TBARS accumulation and decreased the swelling of mito-
chondria can be explained by 2-TeCD acting as a GPX mimic,
which e¡ectively scavenged hydroperoxides and protected mi-
tochondria against oxidative damage.
In conclusion, we have prepared a novel class of GPX
mimic. 2-TeCD is an excellent GPX mimic, as evidenced by
enzymatic properties. These investigations on the mitochon-
dria damage system induced by ferrous sulfate/ascorbate re-
veal that the mimic is a better antioxidant than other GPX
mimics. We anticipate that the mimic may have potential for
the treatment of diseases ranging from acute and chronic in-
£ammation to cataract, cancer, cardiovascular and age-related
diseases.
Acknowledgements: We are grateful to the Ministry of Science and
Technology of China (Project numbers G2000078102 and 863-103-
13-01-05) and the National Natural Science Foundation of China
(Project number 200072010) for ¢nancial support.
References
[1] Vaughan, M. (1997) J. Biol. Chem. 272, 18513.
[2] Spector, A. (1995) FASEB J. 9, 1173^1182.
[3] Salvemini, D., Wang, Z.Q., Zweier, J.L., Samouilov, A., Macar-
thur, H., Misko, T.P., Currie, M.G., Cuzzocrea, S., Sikorski, J.A.
and Riley, D.P. (1999) Science 286, 304^306.
[4] Melov, S., Ravenscroft, J., Malik, S., Gill, M.S., Walker, D.W.,
Clayton, P.E., Wallace, D.C., Malfroy, B., Doctrow, S.R. and
Lithgow, G.J. (2000) Science 289, 1567^1569.
[5] Mugesh, G. and Singh, H.B. (2000) Chem. Soc. Rev. 29, 347^
357.
[6] Mugesh, G. and Mont, W.-W.D. (2001) Chem-Eur. J. 7, 1365^
1370.
[7] Mu«ller, A., Cadenas, E., Graf, P. and Sies, H. (1984) Biochem.
Pharmacol. 33, 3235^3239.
[8] Kirby, A.J. (1996) Angew. Chem. Int. Ed. Engl. 35, 707^724.
[9] D’Souza, V.T. and Bender, M.L. (1987) Acc. Chem. Res. 20,
146^152.
[10] Breslow, R. and Dong, S.D. (1998) Chem. Rev. 98, 1997^2011.
[11] Murakami, Y., Kikuchi, J.I., Hisaeda, Y. and Hayashida, O.
(1996) Chem. Rev. 96, 721^758.
[12] Liu, J.Q., Luo, G.M., Ren, X.J., Mu, Y., Bai, Y. and Shen, J.C.
(2000) Biochim. Biophys. Acta 1481, 222^228.
[13] Lansman, R.A., Shade, R.O., Shapiro, J.F. and Avise, J.C.
(1981) J. Mol. Evol. 17, 214^226.
[14] Bradford, M.M. (1976) Anal. Biochem. 72, 248^254.
[15] Pryor, W.A., Stanley, J.P. and Blair, E. (1976) Lipids 11, 370^
379.
[16] Hunter, F.E., Scott, J.A., Ho¡sten, P.E., Guerra, F., Weinstein,
J., Schneider, A., Schutz, B., Fink, J., Ford, L. and Smith, E.
(1964) J. Biol. Chem. 239, 604^613.
[17] Wilson, S.R., Zucker, P.A., Huang, R.R.C. and Spector, A.
(1989) J. Am. Chem. Soc. 111, 5936^5939.
FEBS 25404 26-10-01
X. Ren et al./FEBS Letters 507 (2001) 377^380380
